HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

News In Brief

This article was originally published in The Rose Sheet

  • News

Executive Summary

EC Mulls 2013 Animal Test Ban

You may also be interested in...



EU Panel Confirms Animal-Alternative Tests Will Miss 2013 Deadline

A panel of scientific experts says full replacement of animal tests with non-animal alternatives is not possible by the 2013 deadline set under the Seventh Amendment to the European Cosmetics Directive.

What’s Next? Five Things To Look Out For In April

Generics Bulletin previews the biggest events and changes for industry in the coming month.

Keeping Track: More Rx-To-OTC Switches On Deck After US FDA’s OTC Narcan Approval; Iovance Looks To Bring Cell Therapy To Melanoma

The latest drug development news and highlights form the Pink Sheet’s US FDA Performance Tracker.

Table

View full table

Tags:
Latest Headlines

Bayer Relates Feeling ‘Sexy’ To Quick Relief For Allergies In Astepro Allergy Ad Campaign

Probiotics, Synbiotics May Help With Children’s Stomach Pain But Results Are Inconclusive

L’Oreal Joins Heavyweights Tackling Sustainable Surfactants With Geno Biotech

Health And Wellness Weekly Trademarks Review: 28 March

See All
UsernamePublicRestriction

Register

RS017760

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By